Treatment for Classical Hodgkin Lymphoma in Children and Adolescents
Status:
Recruiting
Trial end date:
2027-12-01
Target enrollment:
Participant gender:
Summary
Reduction of the indication for radiotherapy (RT) in newly diagnosed patients with classical
Hodgkins lymphoma without compromising cure rates. Investigation of a chemotherapy
intensification randomisation in intermediate and advanced classical Hodgkins lymphoma
patients to compensate for reduction in RT.